The statistic depicts the leading merger and acquisition deals in the life sciences industry worldwide in the first half of 2018. In the period examined, Bayer's acquisition of Monsanto was the largest M&A deal, with a value of approximately 63 billion U.S. dollars.
Leading merger and acquisition deals in the life sciences segment worldwide in the first half of 2018, by transaction value (in billion U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Pharma and life sciences executives' workforce strategy priorities U.S. 2020
- Value of M&As in the U.S. healthcare and life sciences sector 2009-2021
- Quarterly M&A in the U.S. in healthcare and life sciences sector 2018-2021
- Chinese outbound deals in healthcare industry 2017-2019, by type
- Revenue value from biotechnology companies in Germany 2008-2020
- Biopharmaceutical revenue - statutory health insurance market Germany 2014
- Opinions on integrating technology into life sciences supply chain management 2018
- Drugs developed in biotechnology companies in Germany from 2011 to 2016
- Leading M&A announced deals Japan H1 2018
- Breakdown of biotech and pharma CEO compensation 2018, by component
- Projected future investments among life sciences companies 2018
- Top large pharma companies in CEO compensation in 2018
- Market and growth of global life sciences by sector 2016
- Trust levels towards biotech/life sciences by country 2021
- Trust levels towards pharma industry by country 2021
- U.S. pharmaceutical industry spending on research and development 1990-2020
- Share who would go to alternative doctors visits in Sweden 2015-2018, by age
- Export value of pharmaceuticals from Germany 2002-2020
Genetic Engineering & Biotechnology News. (July 2, 2018). Leading merger and acquisition deals in the life sciences segment worldwide in the first half of 2018, by transaction value (in billion U.S. dollars) [Graph]. In Statista. Retrieved June 26, 2022, from https://www.statista.com/statistics/916606/global-life-sciences-leading-merger-and-acquisition-deal-value/
Genetic Engineering & Biotechnology News. "Leading merger and acquisition deals in the life sciences segment worldwide in the first half of 2018, by transaction value (in billion U.S. dollars)." Chart. July 2, 2018. Statista. Accessed June 26, 2022. https://www.statista.com/statistics/916606/global-life-sciences-leading-merger-and-acquisition-deal-value/
Genetic Engineering & Biotechnology News. (2018). Leading merger and acquisition deals in the life sciences segment worldwide in the first half of 2018, by transaction value (in billion U.S. dollars). Statista. Statista Inc.. Accessed: June 26, 2022. https://www.statista.com/statistics/916606/global-life-sciences-leading-merger-and-acquisition-deal-value/
Genetic Engineering & Biotechnology News. "Leading Merger and Acquisition Deals in The Life Sciences Segment Worldwide in The First Half of 2018, by Transaction Value (in Billion U.S. Dollars)." Statista, Statista Inc., 2 Jul 2018, https://www.statista.com/statistics/916606/global-life-sciences-leading-merger-and-acquisition-deal-value/
Genetic Engineering & Biotechnology News, Leading merger and acquisition deals in the life sciences segment worldwide in the first half of 2018, by transaction value (in billion U.S. dollars) Statista, https://www.statista.com/statistics/916606/global-life-sciences-leading-merger-and-acquisition-deal-value/ (last visited June 26, 2022)